SkinHealth Systems (SKIN) Earnings Analysis
SkinHealth Systems (SKIN) next reports earnings on 2026-08-06, consensus EPS -0.04 USD. Last quarter (2026-05-07) it beat with EPS -0.05 USD vs -0.09 USD est (+44.4%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E -13.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SKIN next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.04 USD |
| Revenue estimate | 0.07B |
SKIN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.05 USD | -0.09 USD | +44.4% | Beat |
| 2026-03-12 | -0.06 USD | -0.07 USD | +14.3% | Beat |
| 2025-11-06 | -0.09 USD | -0.08 USD | -12.5% | Miss |
| 2025-08-07 | 0.03 USD | -0.06 USD | +150% | Beat |
| 2025-05-08 | -0.08 USD | -0.13 USD | +38.5% | Beat |
| 2025-03-12 | -0.08 USD | -0.1 USD | +20% | Beat |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
SKIN valuation and analyst view
| Trailing P/E | -13.60 |
|---|---|
| Trailing EPS | -0.04713 USD |
| Price / book | 1.75 |
| Dividend yield | 0.00% |
| Market cap | 0.10B |
| Analyst consensus | Hold (4 buy / 7 hold / 3 sell) |
| Avg price target | 1.5 USD |
Related research pages
Frequently asked questions
When is SkinHealth Systems (SKIN)'s next earnings date?
SkinHealth Systems is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.04 USD and revenue estimate of 0.07B.
Did SKIN beat earnings last quarter?
In its 2026-05-07 report, SKIN posted EPS of -0.05 USD versus a -0.09 USD estimate — a beat of 44.4%.
What is SKIN's earnings track record?
Over the last 6 reported quarters with consensus data, SKIN beat estimates 5 times (83%).
What is SKIN's current P/E ratio and EPS?
SKIN trades at a trailing P/E of -13.60 on trailing EPS of -0.047131050479906074 USD.
What do analysts rate SKIN?
Analyst consensus is "Hold" across 14 ratings (0 strong buy, 4 buy, 7 hold, 3 sell, 0 strong sell). Average 12-month price target: 1.5 USD.